- Home
- SF vs ASND Comparison
SF vs ASND Comparison
Compare SF & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SF
- ASND
- Stock Information
- Founded
- SF 1890
- ASND 2006
- Country
- SF United States
- ASND Denmark
- Employees
- SF N/A
- ASND N/A
- Industry
- SF Investment Bankers/Brokers/Service
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- SF Finance
- ASND Health Care
- Exchange
- SF Nasdaq
- ASND Nasdaq
- Market Cap
- SF 9.8B
- ASND 10.6B
- IPO Year
- SF N/A
- ASND 2015
- Fundamental
- Price
- SF $107.33
- ASND $173.10
- Analyst Decision
- SF Hold
- ASND Strong Buy
- Analyst Count
- SF 8
- ASND 16
- Target Price
- SF $105.14
- ASND $218.19
- AVG Volume (30 Days)
- SF 662.6K
- ASND 409.2K
- Earning Date
- SF 07-23-2025
- ASND 05-01-2025
- Dividend Yield
- SF 1.72%
- ASND N/A
- EPS Growth
- SF 19.51
- ASND N/A
- EPS
- SF 5.24
- ASND N/A
- Revenue
- SF $5,030,597,000.00
- ASND $398,509,511.00
- Revenue This Year
- SF $7.38
- ASND $75.05
- Revenue Next Year
- SF $9.94
- ASND $78.14
- P/E Ratio
- SF $20.39
- ASND N/A
- Revenue Growth
- SF 14.86
- ASND 12.06
- 52 Week Low
- SF $73.27
- ASND $111.09
- 52 Week High
- SF $120.64
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- SF 77.41
- ASND 53.51
- Support Level
- SF $96.54
- ASND $167.52
- Resistance Level
- SF $98.33
- ASND $180.78
- Average True Range (ATR)
- SF 2.21
- ASND 5.70
- MACD
- SF 0.80
- ASND -0.71
- Stochastic Oscillator
- SF 98.04
- ASND 44.91
About SF Stifel Financial Corporation
Stifel Financial is a middle-market-focused investment bank that produces more than 90% of its revenue in the United States. Approximately 67% of the company's net revenue is derived from its global wealth management division, which supports over 2,000 financial advisors, with the remainder coming from its institutional securities business. Stifel has a history of being an active acquirer of other financial-services firms.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.